HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2018
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis E
- Focus Therapeutic Use
- Acronyms HepNet Pilot Trial; HepNet-SofE study
- 06 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Feb 2018 Last checked against European Clinical Trials Database record.
- 04 Dec 2017 Planned End Date changed from 1 Dec 2018 to 1 Mar 2019.